Patricia C. Kuszler, Financing Clinical Research and Experimental Therapies: Payment Due, But from Whom?, 3 DePaul J. Health Care L. 441 (2000), https://digitalcommons.law.uw.edu/faculty-articles/379
DePaul Journal of Health Care Law
health and medical research
This article will explore the realm of clinical research and the question of who should finance such research. The first part will define the various types and levels of clinical research in terms of the regulatory controls and oversight applied to such research. Then the article will summarize how the costs of clinical research and experimental therapies have been covered in the past. Finally, the article will evaluate the risks and benefits derived by the various stakeholders and propose a financing rationale for therapies that places the burden of cost squarely on the stakeholders most likely to benefit.